Back to top

Argus Research Keeps Their Buy Rating on Quest Diagnostics (DGX)

Argus Research analyst David Toung maintained a Buy rating on Quest Diagnostics yesterday and set a price target of $260.00. Toung covers the Healt...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Quest Diagnostics Incorporated (DGX)